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Abstract
Background: Vascular endothelial growth factor (VEGF) is well known for its role in normal and pathologic
neovascularization. However, a growing body of evidence indicates that VEGF also acts on non-vascular cells, both
developmentally as well as in the adult. In light of the widespread use of systemic and intraocular anti-VEGF therapies for
the treatment of angiogenesis associated with tumor growth and wet macular degeneration, systematic investigation of the
role of VEGF in the adult retina is critical.
Methods and Findings: Using immunohistochemistry and Lac-Z reporter mouse lines, we report that VEGF is produced by
various cells in the adult mouse retina and that VEGFR2, the primary signaling receptor, is also widely expressed, with strong
expression by Mu ¨ller cells and photoreceptors. Systemic neutralization of VEGF was accomplished in mice by adenoviral
expression of sFlt1. After 14 days of VEGF neutralization, there was no effect on the inner and outer retina vasculature, but a
significant increase in apoptosis of cells in the inner and outer nuclear layers. By four weeks, the increase in neural cell death
was associated with reduced thickness of the inner and outer nuclear layers and a decline in retinal function as measured by
electroretinograms. siRNA-based suppression of VEGF expression in a Mu ¨ller cell line in vitro supports the existence of an
autocrine role for VEGF in Mu ¨ller cell survival. Similarly, the addition of exogenous VEGF to freshly isolated photoreceptor
cells and outer-nuclear-layer explants demonstrated VEGF to be highly neuroprotective.
Conclusions: These results indicate an important role for endogenous VEGF in the maintenance and function of adult retina
neuronal cells and indicate that anti-VEGF therapies should be administered with caution.
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Introduction
The retina is one of the body’s most metabolically demanding
tissues. To ensure adequate nutrient and oxygen delivery, the
retina is supplied by two independent vascular beds, the inner
retinal vasculature and outer choroidal circulation. These vascular
beds have distinct morphologic properties; the inner retinal
vasculature is the site of a blood-tissue barrier and is characterized
by highly impermeable vessels, whereas the choriocapillaris
consists of a highly fenestrated capillary plexus. Vascularization
of the retina (reviewed in [1]) occurs late in gestation and is
restricted to the inner retina. During development, vascular
endothelial growth factor (VEGF) is expressed by astrocytes in the
retinal ganglion cell layer (GCL), by cells of inner nuclear layer
(INL), Mu ¨ller cells, and retinal pigment epithelial cells (RPE) [2,3].
Targeted deletion of VEGF in the RPE results in failure of
choroidal development and loss of visual function [4]. Whereas
formation of the choriocapillaris appears to be independent of
hypoxia [4], formation of the inner retinal vasculature requires
induction of the hypoxia inducible factor-1b [5]. Hyperoxia
during retinal development suppresses VEGF production resulting
in reduced vascular development [5], as is seen in retinopathy of
prematurity [6]. Furthermore, normal retinal vascularization
requires the coordinated expression of specific VEGF isoforms,
which differ in their solubility and binding to VEGF receptors [7].
In addition to its role in developmental retinal vascularization,
VEGF is upregulated in several ocular pathologies, including wet
age related macular degeneration (AMD) [8] and proliferative
diabetic retinopathy [9]. In AMD, injury to the RPE is thought to
result in increased VEGF expression. Coupled with damage to
Bruch’s membrane, this leads to proliferation of choroidal vessels,
which invade the subretinal space [10]. In proliferative diabetic
retinopathy, the neovascularization that arises from the inner
retina is mediated by hypoxia-induced VEGF (reviewed in [11]).
PLoS ONE | www.plosone.org 1 November 2008 | Volume 3 | Issue 11 | e3554The involvement of VEGF in AMD has led to the Food and Drug
Administration approval of two intraocular anti-VEGF drugs,
pegaptanib sodium (Macugen, OSI/Eyetech Pharmaceuticals,
NY) [12], an aptamer which was reported to inhibits only
VEGF165, and ranibizumab (Lucentis, Genentech) [13], a Fab
fragment of the humanized monoclonal VEGF antibody bevaci-
zumab (Avastin, Genentech) which neutralizes all VEGF isoforms.
While the role of VEGF in developmental and pathologic
retinal vascularization is well understood, its function in the
normal adult is unclear. We and others have previously reported
that VEGF is expressed in the adult retina by RPE [3] as well as by
neuronal and glial cells [14,15,16,17]. Although initially thought
to be endothelial-specific, VEGF has been shown to target a
variety of non-vascular cells (reviewed in [18]) including, neural
stem cells [19], ependymal cells [20] and neuronal cells of the
central nervous system [21,22]. In addition, VEGF neutralization
in humans via intraocular injection of Macugen and Avastin is
associated with an increased incidence of retinal tears [23,24].
Similarly, preeclampsia, which is mediated in part by elevated
circulating levels of a soluble form of VEGF receptor 1 called sFlt1
leading to systemic VEGF neutralization [25], is also associated
with ocular symptoms including RPE lesions, choroidal ischemia
and retinal detachments [26,27].
Given the expression of VEGF and VEGF receptor 2 (VEGFR2)
inthe adultretina,andthe constitutiveactivation ofthe receptor,we
hypothesized that VEGF plays a role in maintenance and function
of the adult retina.Wereportthat,inaddition tothe choriocapillaris
and retinal vasculature, VEGFR2 is expressed by adult photore-
ceptorcellsandMu ¨llercells.WhilesystemicneutralizationofVEGF
in the mouse did not lead to detectable changes in retinal vascular
perfusion or permeability, there wassignificant cell death in the INL
and outer nuclear layer (ONL) as well as loss of visual function. A
direct survival function for VEGF was demonstrated using a Mu ¨ller
cell line as well as primary photoreceptor cells and sheets. Taken
together, these observations implicate VEGF in maintenance of the
adult neural retina.
Results
VEGF and VEGFR2 expression in adult retina
We have previously shown that VEGF is expressed by
embryonic and adult RPE [3]. To examine VEGF expression
patterns in adult eye, we used mice heterozygous for the LacZ
reporter gene with a nuclear localization signal under the control
of the VEGF promoter (28). Here we show that VEGF is also
expressed by cells in the GCL and INL in the adult mouse retina
(Figure 1A, arrowheads and asterisks, respectively). To determine
the identity of the cells expressing VEGF in the GCL, flat-
mounted retinas from adult VEGF-LacZ mice [28] were co-
labeled for lac-Z and for NG2, the chondroitin sulfate proteogly-
can, as a pericyte marker [29]. There were two distinct
populations of Lac-Z positive cells. One was pericytes, identified
by their expression of NG2 and their characteristic abluminal
association with the microvessels (Figure 1B arrowheads). The
second population of VEGF-expressing cells in the innermost
retinal layer were astrocytes (Figure 1B arrow and Figure S1). In
the retina, astrocytes are characterized by cell bodies that are
located in the intercapillary spaces but with processes closely
associated with the microvessels. Immunohistochemical localiza-
tion of the astrocyte marker, glial fibrillary acidic protein (GFAP)
[30], on VEGF-LacZ adult retina confirmed this second VEGF
expressing cell population to be astrocytes (Figure S1). This
pattern of VEGF expression in the GCL is consistent with our
previous observations in postnatal retinal development [2].
To precisely identify the cellular targets of VEGF, we examined
sections of retinas from heterozygous VEGFR2-lacZ mice where
the 59 region of the VEGFR2 gene was replaced with a
promoterless lacZ gene from Escherichia Coli [31]. b-gal staining
revealed that VEGFR2 was expressed by vascular cells in the GCL
(Figure 1D, arrowhead) and INL as well as by the photoreceptors
(ONL and inner segments) (Figure 1C, arrows). Consistent with
the lac-Z staining, VEGFR2 expression, determined by immuno-
chemistry, was observed throughout most of the neural retina
(Figure 1D). Strong VEGFR2 immunoreactivity was noted in
retinal microvasculature (Figure 1D, arrowhead). The comparison
of VEGFR2 expression pattern with the Mu ¨ller cell marker,
cellular retinaldehyde binding-protein (CRALBP) [32] (Figure 1F),
indicated expression of VEGFR2 by Mu ¨ller cells. Mu ¨ller cell
nuclei are localized in the INL and they project processes that
extend from the inner limiting membrane to the outer part of the
ONL. Immunodetection of VEGFR1 revealed a punctuate
staining of the inner and outer plexiform layers as well as of the
inner segments (IS) of photoreceptors (Figure 1E). RT-PCR of
adult rat retina and purified Mu ¨ller cells revealed enrichment of
RNA for VEGF as well as VEGFR1, VEGFR2 and neuropilin-1
(NP1) signals in Mu ¨ller cells, suggesting that Mu ¨ller cells are a
significant source of VEGF and its receptors in the retina. The
localization of VEGF receptors in the IS of the photoreceptors was
confirmed by RT-PCR analysis of VEGFR1 and VEGFR2 on
freshly isolated adult mouse photoreceptors (Figure 1H).
Examination of the activation status of VEGFR2, the main
signaling receptor for VEGF, was accomplished by immunopre-
ciptation from pooled adult retina lysates, followed by immuno-
blotting for phosphorylated tyrosine. Results of this analysis
indicated that VEGFR2 is constitutively activated in the adult
retina (Figure 1I), an observation that is consistent with a role of
VEGF in adult retina homeostasis.
Systemic VEGF neutralization does not affect retinal
vasculature
To elucidate the function of VEGF in the adult retina, we
neutralized VEGF systemically using an adenovirus expressing
sFlt1 (Ad-sFlt1). sFlt1, a soluble form of VEGFR1 produced by
alternative mRNA splicing, is a potent VEGF inhibitor [33]. As
prior reports indicate a role for VEGF in maintenance of the
microvasculature of various organs, including the trachea,
pancreas and thyroid [34], we first sought to determine if systemic
sFlt1-expression led to any changes in retinal vessels. Examination
of retinal flat mounts from fluorescein-perfused mice expressing-
sFlt1 for 14 days revealed no gross changes in the retinal
vasculature (Figure 2A). Collagen IV immunostaining of retinal
sections from fluorescein-dextran perfused mice revealed normal
perfusion in the retinas of mice that had expressed sFlt1 for 14
days compared to controls (Figure 2B and C). NG2 staining of
retinal flat mounts from sFlt1-expressing mice showed no apparent
changes in pericyte association to the retinal microvessels (Figure
S2).
As it has been previously shown that systemic neutralization of
VEGF leads to increased permeability in the lung and kidney of
sFlt1-expressing rats [35] and in the brain of sFlt1-expressing mice
[20], we sought to determine if systemic VEGF neutralization
would affect the permeability of the retinal vasculature. The vessels
of the retinal vasculature have properties similar to the blood brain
barrier, and as such, are relatively impermeable [36]. Fluorescein
angiography of the retina demonstrated no differences in
fluorescein leakage between mice expressing Ad-null or Ad-sFlt1
for seven days (Figure 2D). Transmission electron microscopic
examination of the retinal vasculature did not reveal structural
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(Figure 3A and B). The capillaries of the GCL of sFlt1-expressing
mice displayed normal morphology with well-defined extracellular
space and basement membrane, few cytoplasmic vacuoles and
normal tight junctions (Figure 3A).
Similarly, there were no structural abnormalities of the RPE-
choriocapillaris complex. The Bruch’s membrane of sFlt1-
expressing mice appeared normal with well defined layers and
no apparent thickening. No sign of thrombosis could be detected
(Figure 3B). The choriocapillaris retained their characteristic
fenestrated phenotype (Figure 3C). Electron microscopic quanti-
fication of fenestrations in the choriocapillaris endothelium of mice
expressing sFlt1 for 28 days showed no difference compared to the
Ad-null infected controls (Figure 3D).
VEGF neutralization leads to neuroretinal cell apoptosis
and loss of retinal function
Examination of retinal cryosections from mice expressing sFlt1
for 14 days revealed significant apoptosis in both the INL and
ONL (Figure 4A–B). Retinal damage is generally associated with
Mu ¨ller cell activation that is marked by upregulation of GFAP
[37]. However, there was no increase in GFAP expression in
Mu ¨ller cells of mice expressing sFlt1 for 14 days (Figure S3),
suggesting that the observed cell death is not the consequence of
any ongoing retinal injury. The increased cell death resulted in a
significant reduction in the thickness of the INL and ONL by day
28 (Figure 5A).
The INL is comprised primarily of Mu ¨ller and neural cells,
including bipolar, horizontal and amacrine cells, whereas the
ONL contains photoreceptor cell bodies. Electron micrographs
revealed typical signs of apoptosis in various cells of the INL.
Apoptotic Mu ¨ller (Figure 5B) and amacrine cells (Figure 5C) could
be identified based on their location and morphological charac-
teristics [38]. Both cells showed chromatin condensation, mem-
brane swelling and ruptured mitochondria (Figure 5B and C). Cell
death was even more evident in the ONL where a high number of
photoreceptor cell bodies displayed cellular shrinkage, and
chromatin condensation (Figure 5D). The combination of
Figure 1. VEGF signaling in the adult retina. (A) Sections of eyes from adult VEGF-lacZ mice stained for LacZ using x-gal (blue) revealed VEGF
expression in the GCL (arrowheads) and INL layer (asterisks). (B) Flat-mounted retinas from adult VEGF-lacZ mice stained for lacZ (blue) and NG2
(brown) demonstrated VEGF expression by NG2-positive cells associated with microvessels (arrowhead) and by some astrocytes (arrow) in the GCL.
(C) Sections of eyes from adult VEGFR2-lacZ mice stained for lacZ revealed expression of VEGFR2 in the GCL, in the INL (asterisks), and in the
photoreceptors where a strong lacZ staining was observed in the inner segments (arrows). (D) Immunohistochemistry for VEGFR2 in sections of adult
retina revealed expression in vascular cells (arrowhead), in Mu ¨ller cells processes, and in the IS of the photoreceptors (arrows). (E)
Immunohistochemistry for VEGFR1 revealed a spotty expression in the IPL and OPL. VEGFR1 was also detected in the photoreceptor IS. (F)
Staining of Mu ¨ller cells using CRALBP revealed an expression pattern similar to VEGFR2 (compare with D). (G) Expression of VEGF and its receptors,
VEGFR1 and VEGFR2, by Mu ¨ller cells was confirmed by RT-PCR of RNA from adult rat retina and isolated rat Mu ¨ller cells. (H) Expression of VEGFR1 and
VEGFR2 in photoreceptors (PR) isolated from adult mouse retinas. (I) Immunoprecipitation (IP) of VEGFR2 from pooled adult mouse retinas, followed
by immunoblotting for phosphorylated tyrosine revealed VEGFR2 expression (bottom panel) and activation (top panel) in the adult retina. As a
control, lysates of porcine aortic endothelial (PAE) cells overexpressing VEGFR2 either untreated or stimulated with VEGF were immunoprecipitated
and immunoblotted as described above. GCL: ganglion cell layer, IPL: inner plexiform layer, INL: inner nuclear layer, OPL: outer plexiform layer, ONL:
outer nuclear layer, IS: inner segment, OS: outer segment. Scale bar is 100 mm.
doi:10.1371/journal.pone.0003554.g001
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(MP), which are normally closely associated with the photorecep-
tors, left large empty spaces containing cellular debris (Figure 5D).
Visual dysfunction resulting from the increased cell death
observed in sFlt1 expressing mice was assessed using electroret-
inogram (ERG) recordings. The ERG results from the electric
current created by light-induced activity of neuronal and glial cells
[39]. ERG recording revealed a significant reduction of both a-
and b-wave amplitude (Figure 5E). Reduction of more than half of
the a-wave amplitude is indicative of a considerable loss of
photoreceptor function and is consistent with our previous
observations. The reduction of the b-wave is a sign of an altered
photoreceptor post-synaptic cascade that reflects the increase in
photoreceptor apoptosis. A possible contribution of bipolar cell
dysfunction to the reduced b-wave could not be excluded.
Autocrine VEGF signaling plays a role in Mu ¨ller cell
survival
In light of the co-expression of VEGF and its receptors by
Mu ¨ller cells, we investigated whether the disruption of a VEGF
autocrine pathway on Mu ¨ller cells was mediating the increased cell
death in the INL of sFlt1 expressing mice. Because of the technical
difficulty to isolate sufficient numbers of differentiated Mu ¨ller cells,
we used the Mu ¨ller cell line, MIO-M1. MIO-M1 is a
spontaneously immortalized human Mu ¨ller cell line that retains
most of the characteristic Mu ¨ller cell morphology, protein
expression and function [40]. We used siRNA mRNA to alter
autocrine VEGF signaling by inhibiting its autonomous expres-
sion. Transfection of siVEGF led to a 76% decrease in VEGF
mRNA (Figure 6A) and a 94% reduction of secreted VEGF
protein (from 1.63 ng/ml60.01 to 0.1 ng/ml60.01) at day 3
(Figure 6B). Inhibition of VEGF expression under serum-free
conditions led to an increase in the number of TUNEL-positive
MIO-M1 cells (Figure 6C). Quantification of apoptosis by FACS
analysis revealed a doubling in the number of apoptotic cells in
siVEGF-transfected cells compared to cells transfected with
control siRNA (Figure 6D).
Apoptosis is tightly controlled by the balance between pro- and
anti-apoptotic genes of the Bcl-2 family. Changes in the relative
expression of the Bcl-2 family members in favor of pro-angiogenic
genes will ultimately decide cell fate [41]. Therefore, we
determined the expression level of the pro-apoptotic gene Bax
and anti-apoptotic genes Bcl-2 and Bcl-xL by quantitative PCR.
Inhibition of VEGF expression by MIO-M1 cells resulted in the
up-regulation of the pro-apoptotic gene Bax (Figure 6E), leading to
a significant increase in the Bax/Bcl-2 expression ratio (Figure 6F).
No significant changes in Bcl-2 and Bcl-xL expression were
detected (data not shown).
VEGF is a direct survival factor for photoreceptors
Based on our observation that photoreceptors express VEGF
receptors, we used freshly isolated post-mitotic mouse photore-
ceptors to determine if VEGF could directly influence photore-
ceptor survival. Photoreceptor sheets were isolated by mechanical
fractionation of flat-mounted retinas (Figure S4). Purity of the
preparation was controlled by co-immunodetection of the
photoreceptor marker, recoverin, and the Mu ¨ller cell markers,
Figure 2. VEGF neutralization does not affect retinal vascular
perfusion or permeability. Mice infected with Ad-null or Ad-sFlt1 for
14 days were perfused with h.m.w fluorescein dextran (green), then
eyes were dissected and (A) flat mounted or (B) sectioned and
immunostained for collagen IV, and visualized with a Cy3-conjugated
secondary antibody (red). (A) Flat mounts of retinas from mice
expressing sFlt1 perfused with fluorescein dextran shows no gross
abnormalities or perfusion defects, and no changes in capillary density
in the inner retina compared to the control mice expressing Ad-null
(n=6 mice/condition). (B) Immunofluorescent localization of collagen
IV in sections of fluorescein-perfused retinas revealed nearly complete
overlay of FITC-dextran and collagen IV of the inner retinal vessels in
both Ad-null and Ad-sFlt1 (arrows, third column). (C) Quantification of
fluorescein- and collagen IV-positive vessels of the innermost retinal
vasculature in Ad-sFlt1 (n=5) compared to Ad-null (n=4) showed no
reduction in the number of perfused vessels, indicating the absence of
vascular damage. (D) Fluorescein angiography of experimental mice
seven days after infection showing no opacity in the vitreous 4-5 min
after injection in either group, indicating no change in retinal vascular
permeability (n=6 mice/condition). Scale bar is 1 mm in A and 100 mm
in B.
doi:10.1371/journal.pone.0003554.g002
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photoreceptor cells cultured in absence of serum died rapidly (as
measured by Trypan blue exclusion) (Figure 7A). However, the
addition of 10 ng/ml of VEGF165 was sufficient to rescue the
photoreceptors, so that at 72 hr there were only 8.2% apoptotic
cells in the presence of VEGF compared to 37.4% in the absence
of VEGF (Figure 7B). This pro-survival function of VEGF was
confirmed using photoreceptor explants in which 60 mm sections
containing only the photoreceptor cell bodies and their inner
segments were cultured in presence or absence of VEGF165. As
observed with isolated photoreceptor cells, the absence of serum
resulted in a time-dependent increase in apoptosis while the
addition of VEGF led to significant protection against apoptosis
(Figure 7C–D).
Discussion
There is growing evidence that VEGF effects are not specific to
the vasculature. A variety of non-vascular cells express VEGFR2,
the primary VEGF signaling receptor, and VEGF has been shown
to act on these cells to mediate proliferation, differentiation and/or
survival (for review see [18]). Previous studies reported the
expression of VEGFR2 by glial and neuronal cells of the retina
[14,42,43,44] but VEGFR2 expression by photoreceptors has not
been definitively established [43,45]. The combined use of
VEGFR2-LacZ mice and immunohistochemistry for VEGFR2
allow us to unequivocally demonstrate the expression of VEGFR2
on Mu ¨ller cells and photoreceptors. The wide expression of VEGF
and VEGFR2 in adult retina and the finding that VEGFR2 is
constitutively phosphorylated strongly indicates a role for VEGF
Figure 3. Systemic VEGF blockade does not alter retinal vessels ultrastructure or choriocapillaris fenestration. (A) TEM of a
microvessel located in the GCL of sFlt1 expressing mouse at day 14 showed a normal ultrastructure of the endothelial nuclei and cytoplasm.
Characteristically electron -dense tight junctions were well defined (arrows). (B) TEM micrograph of the outer segment of a retina, 14 days post-
infection of Ad-sFlt1, revealed a normal RPE-choroid complex. The RPE basal infoldings were dense and well associated with the Bruch’s membrane
(BM). The choriocapillaris showed no thickening of the membrane. No sign of thrombosis were detected. (C) Higher magnification of the
choriocapillaris revealed numerous fenestrations on the endothelial membrane facing the RPE (arrows). (D) Endothelial fenestrations of the
choriocapillaris (arrows) were quantified at 28 days post-infection on TEM micrographs (n=3 mice/condition). No change in the number of
choriocapillaris fenestration was observed between Ad-null and Ad-sFlt1 mice. Scale bar is 5 mm in A–B, 0.5 mm in C and 1 mmi nD .
doi:10.1371/journal.pone.0003554.g003
Figure 4. VEGF neutralization leads to increased retina cell
death. (A) TUNEL staining showed markedly increased apoptosis in
both the INL and ONL of Ad-sFlt1 mice 14 days post-infection (n=4
mice/condition). (B) Higher magnification images of retinal sections of
sFlt1-expressing mice stained for TUNEL and counterstained with
hematoxylin revealed an significant increase in the number of apoptotic
cells in the INL and ONL. GCL: ganglion cell layer, INL: inner nuclear
layer, ONL: outer nuclear layer, OPL: outer plexiform layer, Ch: choroid.
Scale bars are 100 mm in A and 50 mmi nB .
doi:10.1371/journal.pone.0003554.g004
VEGF & Retinal Function
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role of VEGF in the normal retina by systemic neutralization.
Systemic blockade was selected over intravitreal injection because
these studies are intended to assess the effect of sustained and long-
term VEGF inhibition in adult mice.
The observation that Mu ¨ller cells, which express both VEGF as
well as its receptors, VEGFR1 and VEGFR2, undergo apoptosis
in mice with systemic VEGF neutralization suggested an autocrine
role for VEGF in Mu ¨ller cells in vivo. This concept is strongly
supported by the finding that siRNA suppression of VEGF
expression in cultured Mu ¨ller cells leads to a significant increase in
cell death. Co-expression of VEGF and VEGFR2 has been
observed in many tumor cells [46,47] but only in a few normal cell
types, such as podocytes [48], skeletal muscle [49], aortic
endothelium [50,51], and RPE [3]. However, a role for VEGF
autocrine pathways in tissue homeostasis has only been
demonstrated in vivo in the endothelium, where cell-autonomous
signaling of VEGF appears to be required for endothelial cell
survival [51].
Our data showed that VEGF autocrine signaling promotes
Mu ¨ller cell survival in serum-free conditions through the control of
pro-apoptotic Bax gene expression. Interestingly, no changes in the
level of expression of anti-apoptotic genes Bcl-2 and Bcl-xL were
observed after alteration of VEGF autocrine signaling. Bax
constitutes one of the main transcriptional targets of p53 in
neuronal and glial cells [52] suggesting that VEGF autocrine
signaling regulates Mu ¨ller cell apoptosis through the control of p53
expression/activation and Bax expression.
The physical association between the photoreceptors that
express VEGFR2 and the Mu ¨ller cells that express VEGF points
to a paracrine interaction in which Mu ¨ller cells provide VEGF as a
neurotrophic signal to photoreceptors. The dramatic increase in
Figure 5. Decreased retina thickness and loss of visual function in sFlt1 expressing mice. (A) Semi-thin epon sections from retinas of
experimental mice expressing sFlt1 for 28 days showed substantial thinning of the INL (black double arrowheads line) and the ONL (white double
arrowheads line) (n=3 for Ad-null and n=4 for Ad-sFlt1). (B–D) TEM of retinas from sFlt1 expressing mice at 28 days. (B–C) Micrographs taken in the
INL region revealed apoptotic Mu ¨ller cells (MC) and amacrine cells (A). Both cells displayed condensation of the chromatin, membrane swelling and
rupture mitochondria (arrows). (D) In the ONL, a high percentage of photoreceptors appeared apoptotic (white asterisk). Cell death left numerous
empty spaces containing membranous debris (arrowhead). Processes from the Mu ¨ller cells that normally fill the intercellular space appeared
shrunken (MP). (E) Scotopic ERG recordings of experimental mice 28 days post-infection using a flash intensity of +10 dB revealed a marked reduction
of both a- and b-wave amplitudes in sFlt1-expressing mice (n=6 for Ad-null and n=10 for Ad-sFlt1). GCL: ganglion cell layer, INL: inner nuclear layer,
ONL: outer nuclear layer, OPL: outer plexiform layer, Ch: choroid. Scale bars are 100 mm in A and 5 mm in B to D.
doi:10.1371/journal.pone.0003554.g005
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expressing sFlt1 is consistent with this suggestion. Using purified
photoreceptors, we were able to demonstrate a direct function of
VEGF on photoreceptor survival independent of an effect on
accessory cells. Mu ¨ller cells act to support retinal neurons by
providing structural support for the retina and regulating ion and
neurotransmitter levels in the extracellular space [53]. In addition,
they produce a variety of neurotrophic factors, including brain-
derived neurotrophic factor (BDNF) [54], nerve growth factor
(NGF) [55] and neurotrophins (NT-3 and NT-4/5) [56]. Our
findings add VEGF to this list. Though retinal pigment epithelial
cells (RPE) also produce VEGF in the adult [3], they are unlikely
to be a primary source of VEGF for the photoreceptors because of
their distance from the photoreceptor cell bodies. Moreover, RPE
Figure 6. Inhibition of the autocrine VEGF signaling in Mu ¨ller cells leads to increased cell death. VEGF expression by MIO-M1 Mu ¨ller cells
was inhibited by transfection of siRNA into sub-confluent cells. (A–B) Seventy-two hr following transfection of the control and VEGF siRNA, VEGF
mRNA levels were determined by qPCR (A) and VEGF protein secretion was quantified by ELISA (B). siVEGF transfection led to a 75% inhibition of
VEGF mRNA and more than 90% reduction of VEGF protein (n=3). (C) Inhibition of VEGF was associated with an increase in TUNEL-positive cells after
three days of culture in serum-free conditions (n=4). (D) Quantification of cell death by FACS analysis demonstrated a doubling of the number of
annexin-V positive apoptotic cells in siVEGF transfected cells compared to siControl (n=3). (E) Increased apoptosis was accompanied by a significant
up-regulation of the pro-apoptotic gene, bax, and by the increase of the Bax/Bcl-2 ratio (F). Scale bar is 100 mm.
doi:10.1371/journal.pone.0003554.g006
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of the underlying fenestrated choriocapillaris [4]. In addition to
supporting photoreceptors, Mu ¨ller cells have been to shown to
maintain adult retinal ganglion cell (RGC) survival in vitro [57]
and the fact that RGC express VEGFR2 [43] suggests that Mu ¨ller
cell-derived VEGF also plays a supporting role for RGCs. In
support of this, it has been demonstrated that long-term VEGF
(8 wk) blockade in the rat leads to RGC apoptosis [43].
The requirement of glial and neuronal cells for VEGF as a
survival factor under normal conditions is one of the most
intriguing findings of our study. Mu ¨ller cells and neurons produce
numerous neurotrophic factors to support the retina [58,59].
Dependence on VEGF signaling may be due to the high metabolic
rates of retinal neurons and their extreme sensitivity to hypoxia
[60]. As VEGF expression is tightly controlled by oxygen tension
and glycemia level [61,62], VEGF would be the ideal candidate to
support retina homeostasis during the early phase of an oxidative
or ischemic insult. Indeed, VEGF has been shown to protect
neuronal cells of the central nervous system (CNS) against
apoptosis induced by serum deprivation or hypoxia [63]. The
Figure 7. VEGF is a direct survival factor for photoreceptors. (A) Photoreceptors isolated from adult C57BL/6J mice were cultured on laminin-
coated wells in absence or presence of 10 ng/ml VEGF165 for up to 72 hr. Addition of 10 ng/ml of VEGF165 decreased the number of dead cells
identified by trypan blue staining. (B) Quantification of the percentage of dead photoreceptors based on the trypan blue exclusion assay revealed a
significant protection from apoptosis by VEGF165 (n=9). (C) ONL explants containing only the photoreceptor nuclei and IS were cultured in basal
medium610 ng/ml of VEGF165 for 24, 48 and 72 hr. Apoptotic cells were detected by TUNEL staining. (D) Quantification of TUNEL-positive cells per
sheet revealed a significant decreased in the number of apoptotic photoreceptors in presence of VEGF (n=6).
doi:10.1371/journal.pone.0003554.g007
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and photoreceptors that we have revealed here parallels the
trophic association between Schwann cells and neurons in the
CNS [64].
We have previously observed VEGF expression in virtually all
vascularized adult tissues [50,65] and we and others have
hypothesized that VEGF plays an important role in the
maintenance of the adult vasculature [34,50]. In support of this,
relatively short-term systemic VEGF neutralization has been
shown to lead to the selective regression of some fenestrated
microvessels [34], leading to the hypothesis that these fenestrated
vessels are particularly dependent on VEGF for their survival. In
fact, we have shown that nearly all fenestrated vessels, including
for example the glomerulus of the kidney and the chroroid plexus
in the brain, lie in close proximity to epithelial cells that express
high levels of VEGF [50]. Studies in vitro and in vivo [66,67] have
demonstrated that ectopic application of VEGF can induce the
formation of fenestrations. Interestingly, our analysis did not reveal
an effect of systemic VEGF neutralization on the fenestrations of
the choriocapillaris. A recent report in which intravitreal
administration of Avastin in a primate model led to early loss of
fenestration with rapid recovery in spite of the prolonged Avastin
half-life [68], leads us to speculate that the loss of fenestrations is a
transient effect that one might not expect to be detectable at this
later (28 days post infection) time point.
Our observation of relatively low levels of VEGF in the
innermost retinal layers and the fact that systemic VEGF
expression does not influence the inner retinal vasculature, which
is not fenestrated but is the site of the blood neural barrier, are
consistent with the idea that high local VEGF levels reflect a
particular dependence on VEGF, which renders them particularly
sensitive to systemic VEGF blockade. Consistent with this notion,
the microvasculature of the brain, which has relatively low levels of
VEGF in the adult [50], was not influenced by 14 days of systemic
VEGF inhibition [34]. In addition to the relatively low levels of
local VEGF, the microvasculatures of the retina and brain are
characterized by high ratio of pericyte to endothelial cells [69]. In
light of the evidence that pericyte association with EC mediates
vessel stabilization, it is reasonable to suggest that the microvas-
culature of the CNS is particularly stable. On the other hand, it is
difficult to evaluate the extent of VEGF neutralization at the level
of the retinal microvasculature by systemically expression of sFlt1.
Based on our previous extensive use of endothelial cell-pericytes
cocultures [70,71] and the documented close association between
endothelial cells and pericytes in the retina [72,73], we suspect that
the VEGF produced by pericytes to support retinal capillary
endothelial cells (Figure 1D in this paper and [2]) may be relatively
less accessible to soluble Flt-1 and thus may account for the lack of
an effect of VEGF neutralization on the inner retinal vessels in the
time frame of this study.
Our results have obvious implications for therapeutic use of
anti-VEGF, particularly as it relates to the eye, as we observed that
VEGF neutralization interferes with endogenous survival signals,
leading to unexpected neural toxicity. On the other hand,
however, since the adult retina expresses VEGF in the absence
of active neovascularization, it is clear that the locally produced
VEGF mediates neural protection without leading to vessel
permeability or growth. The absence of active vessel prolifera-
tion/permeability in the normal retina in the presence of
endogenous VEGF may be due to the dose, localization and/or
the presence of opposing factors, such as TGF-b [74,75] or
angiopoietin-1 [76]. However, it does indicate that, with
appropriate delivery and/or dosing, VEGF may find use as a
neural survival factor for degenerative retinal pathologies.
Materials and Methods
Animals
Adult VEGF-lacZ mice (from Andreas Nagy, University of
Toronto, Canada) [28] and adult VEGFR2-lacZ mice [31]
(generous gift of Victoria Bautch, UNC-Chapel Hill, NC) were
used for localization of VEGF and VEGFR2, respectively. Adult
C57BL/6J mice were used for analysis of VEGFR expression and
subsequent VEGF-induced photoreceptor survival (JAX Labora-
tories). For in vivo neutralization of VEGF, adult CD-1 mice 6-8
weeks old (Charles River Laboratories) were injected with either
1610
‘10 viral particles (V.P.) Ad-CMV-null (control) or
2.5610
‘9 V.P. Ad-CMV-sFlt1 (murine form consisting of the
first three IgG repeats) [25,77](Q?Biogene) on day 0. sFlt1
expression was confirmed by ELISA (R&D Systems). Ad-CMV-
null and Ad-CMV-sFlt1 did not contain an Ig Fc region. Absence
of systemic immune response was confirmed by the absence of
leukocyte and platelet activation (data not shown). Circulating
levels of sFlt1 of ,200 ng/ml were measured on the plasma
fraction seven days post-infection and were sustained for at least 21
days. Ad-null infected mice showed no detectable sFlt1. All
animal protocols were approved by the Schepens Eye Research
IACUC.
Fluorescein-dextran perfusion
Anesthetized mice were perfused through the aorta with
fluorescein dextran 2610
‘6 m.w. (Sigma) 50 mg/ml in 4%
paraformaldehyde in PBS. Eyes were then removed, fixed in 4%
paraformaldehyde at 4uC overnight and processed for flat-mount
and cryosections.
Immunohistochemistry
For VEGF-lacZ and VEGFR2-lacZ staining, sections and flat-
mounted retinas were stained for LacZ using the in situ b-
galactosidase kit, according to the manufacturer’s instructions
(Stratagene). Flat-mounted retina, cryosections and photoreceptor
explants were incubated overnight at 4uC with rabbit anti-mouse
VEGFR2 T1014 (1:500, a gift from Dr. Brekken, University of
Texas Southwestern Medical Center, Dallas, TX) [78,79], mAb
anti-CRALBP (1:500, Abcam), rabbit anti-VEGFR1 (1:100; Santa
Cruz), rabbit anti-GFAP (1:300, Sigma), mAb anti-GFAP (1:250,
Millipore), rabbit anti-collagen type IV (1:400, Abcam), rabbit
anti-NG2 (1:300; Millipore), mAb anti-GS (1:250, Chemicon),
rabbit anti-recoverin (1:500, Chemicon). Secondary antibodies
included biotinylated anti-rabbit or anti-mouse antibodies (Vector
Laboratories) and Cy5-, Cy3- or FITC-conjugated antibody
(Jackson ImmunoResearch Laboratories). Some antibodies were
visualized using 3, 39-diaminobenzidine (ABC kit; Vector
Laboratories). ECs were detected using FITC-conjugated Griffonia
simplicifolia isolectin B4 (Vector Laboratories). Cell nuclei were
identified by DAPI labeling. Incubation using rabbit or mouse IgG
as a primary antibody was conducted as a negative control.
Quantification of retinal vessel perfusion
Retinal vascular perfusion was measured by comparing the
number of type IV collagen-positive vessels of the inner retina
(GCL) to the number of FITC positive vessels on 3 serial
cryosections separated by 150 mm.
Histology and electron microscopy
Tissues were prepared for TEM as previously described [20].
Ultrathin sections were treated with uranyl acetate and visualized
using a Phillips 410 transmission electron microscope.
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Semi-thin sections were cut along the vertical meridian passing
through the optic nerve and stained with Richardson’s stain for
light microscopy. Three serial sections (100 mm apart) were
quantified per animal. On each section, photographs were taken
at 600 mm and 1800 mm from the optic nerve on each side. Three
measurements were made per photographs. For each animal, the
ONL and INL thickness was obtained by averaging all 36
measurements.
Quantification of choriocapillaris fenestrations
Endothelial fenestrations were quantified from electron micro-
graphs of the peripheral region of the RPE-choroid (approximately
800 mm from the optic nerve) at a magnification of 10,4006. Only
the RPE-side vessel wall was taken into consideration. Fenestra-
tions were counted on 13–15 fields showing continuous chorio-
capillaris lumen with a length of 10 mm each.
VEGFR2 activation status
Adult mouse retinas were dissected, pooled, lysed, and protein
concentration was determined using a BCA assay (BioRad).
VEGFR2 immunoprecipitation and phospho-tyrosine blot was
performed as previously described [3]. As a control, porcine aortic
cells overexpressing human VEGFR2 (PAE-VEGFR2) were
serum-starved overnight and incubated with 50 ng/mlVEGF165
(R&D Systems) for five min. Lysates were then collected and used
for immunoprecipitation.
Fluorescein angiography
Fluorescein angiography was performed after intraperitoneal
injection of 60 mg/kg of 25% fluorescein sodium (Akorn).
Photographs were taken using the Topcon/Imagenet system
(Topcon Medical System) with a preset 20D lens apposed to the
fundus camera at regular time intervals (from 1 min to 4 min post
I.P injection). Fluorescein leakage was noted as diffuse opacity in
the vitreous over-time.
TUNEL assay
Apoptotic cells were detected using the Dead End HRP kit
(Promega) or the Roche In Situ Cell Death Detection TMR red kit
(Roche Diagnostic) following the manufacturer’s instructions.
Electroretinography
Mouse ERG was assessed 28 days post adenovirus infection on
dark-adapted mice using a UTAS-E3000 recording system (LKC,
Technologies, Inc.). After pupil dilatation with 1% tropicamide,
1.5% cyclopentolate, each mouse was placed in front of a
Ganzfeld bowl (UTAS3000; LKC Technologies). ERG responses
to a series of increasing-intensity light flashes: 60, +10 and +20-dB
were averaged over 10 separate flashes per light intensity.
Cell culture
The human Mu ¨ller cell line, MIO-M1 (a gift from G.A. Limb,
Institute of Ophthalmology and Moorfields Eye Hospital, London,
UK), was maintained in culture at 37uC, 5% CO2 in Dulbecco’s
modified Eagle’s medium (DMEM) (Invitrogen Gibco) supple-
mented with 2 mmol/L glutamine, 100 IU/ml penicillin, 100 mg/
ml streptomycin (all from Gibco) and 10% fetal bovine serum
(Sigma). Cells were used from passage P16 to P25. MIO-M1
apoptosis was quantified using the Vybrant Apoptosis Assay #2
(Molecular Probes) followed by flow cytometry using a FACSCAN
flow cytometer.
siRNA mediated gene silencing of VEGF
Inhibition of VEGF expression was achieved using an ON-
TARGETplus SMARTpool containing four pooled siRNA
duplexes (Dharmacon). An unrelated control siRNA pool that
lacks identity with known gene targets was used as a control for
non-sequence-specific effects. MIO-M1 cells were transfected with
siRNA using Dharmafect 1. VEGF in the cell culture supernatant
was determined using a Quantikine human VEGF Immunoassay
kit (R&D Systems).
Reverse Transcription-PCR Analysis
Total RNA was isolated from tissue and cells using RNA-Bee
solution (IsoText Diagnostic Inc.). Mu ¨ller cells were isolated from
adult rat retinas by density gradient centrifugation as described
previously [80] and total RNA isolated using the RNEasy kit
(Quiagen). RNA was reverse-transcribed using Superscript III
(Invitrogen). Standard PCR was performed with 1 U Taq DNA
polymerase (Roche Diagnostics) and 0.2 mM of appropriate
primer pair (Table 1). qPCR reactions were performed using the
SYBR Green Master mix and the ABI Prism 9700 Sequence
Detection System (Applied Biosystems) according to the manu-
facturer’s instructions. For primer sequence, see Table 2.
Isolation of photoreceptor sheets
Sheets of photoreceptors were isolated from adult C57BL/6J
mice as described previously [81,82]. Retinas from 6–8 week old
C57BL/6J mice were dissected and flattened by making 4 radial
cuts, then placed on a 20% gelatin block secured to a vibratome
chuck. Starting at the vitreal surface, sequential sections were cut
until the photoreceptor layer was reached then a 200 mm thick
section, containing the ONL and IS, was collected. In some
experiments the 60 mm thick sections were cultured as ONL
explants in the presence or absence of 10 ng/ml VEGF165 (R&D
Systems) and apoptotic cells per section were quantified by
TUNEL assay.
Trypan blue exclusion assay
Photoreceptor cells collected by enzymatic digestion (papain) of
vibratome-isolated photoreceptor sheets were cultured in 96 well
laminin-coated plates (Sigma) at 37uC under 5% CO2 in
neurobasal medium (Gibco) supplemented with 2% B27 (Gibco),
1% pen/strep (Sigma), 1% glutamine (Sigma) and 0.2% nystatin
(Sigma), in the presence or absence of 10 ng/ml VEGF165 (R&D
Systems, obtained from the NIH-NCI Preclinical Repository).
Twenty-four, 48 or 72 hrs post-plating, 10 ml of trypan blue dye
was added for 5 min and the numbers of stained (dead) and
unstained (live) cells were counted.
Statistical analysis
Values are expressed as mean6SD (unless specified); statistical
analysis was performed using an unpaired Student t test (***:
P,0.001, **: P,0.01, *: P,0.05, ns: P.0.05).
Online supplemental material
Fig. S1 shows VEGF-expressing astrocytes, characterized by
GFAP and b-gal staining, in adult VEGF-LacZ retina flat-mount.
Fig. S2 demonstrates normal pericyte coverage of retinal
microvessels 14 days after Ad-sFlt1 infection. Fig. S3 demonstrates
the absence of GFAP up-regulation in Mu ¨ller cells after Ad-sFlt1
infection. Fig. S4 shows the successive steps of photoreceptor
sheets isolation by vibratome sectioning. Fig. S5 demonstrates the
purity of the photoreceptor explants which stain positive for
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glutamine synthetase (GS).
Supporting Information
Figure S1 Expression of VEGF by astrocytes in adult retina.
VEGF expressing cells were detected on retina flat-mounts of adult
VEGF-lacZ mice by b-gal staining. Co-staining with GFAP
revealed a high number of astrocytes, with processes wrapping the
retina vessels, expressing VEGF as shown by the blue staining of
their cell bodies (black arrowheads). Some lacZ-positive GFAP-
negative cells, presumably pericytes, are observed apposed to the
vessel wall (white arrows). Scale bar are 100 mm.
Found at: doi:10.1371/journal.pone.0003554.s001 (5.90 MB TIF)
Figure S2 Normal pericyte coverage in microvessels of sFlt1
treated mice. Mice expressing Ad-null or Ad-sFlt1 for 14 days
were perfused with h.m.w fluorescein dextran (green), the retinas
were dissected, flat mounted and stained for the pericyte marker,
NG2 (red). No changes in the association of pericytes with the
retinal microvessels were observed (arrows). Scale bar is 50 mm.
Found at: doi:10.1371/journal.pone.0003554.s002 (0.93 MB TIF)
Figure S3 Absence of glial activation in the retina of sFlt1-
expressing mice. Sections of eyes from mice infected by Ad-null
and Ad-sFlt1 for 14 days were stained for the intermediate
filament protein, glial fibrillary acidic protein (GFAP). Upregula-
tion of GFAP in the Mu ¨ller cells endfeet and processes is associated
with an ongoing injury response. However, GFAP appeared
normally restricted to the astrocytes in the GCL of both Ad-null
and Ad-sFlt1 mice. GCL: ganglion cell layer; IPL: inner plexiform
layer; INL: inner nuclear layer. Scale is bar 100 mm.
Found at: doi:10.1371/journal.pone.0003554.s003 (1.06 MB TIF)
Figure S4 Isolation of photoreceptors sheets. Adult mouse
retinas were flat-mounted onto a 20% gelatin block and sectioned
along the horizontal plane until the ONL was reached. (A)
Photograph of a gelatin block stained by hematoxylin and eosin
(H&E) showing that only the photoreceptors (ONL, IS and OS)
remain after the inner layers are sectionned. (B) H&E staining of
an isolated photoreceptor sheet that will be subsequently used for
ONL explant or photoreceptor cell culture. OS: outer segment; IS,
inner segment; ONL, outer nuclear layer. Scale bar is 100 mmi n
A and 50 mmi nB .
Found at: doi:10.1371/journal.pone.0003554.s004 (0.93 MB TIF)
Figure S5 Verification of the photoreceptor explant purity.
ONL explants were co-stained for the photoreceptor marker,
recoverin, and the Mu ¨ller cell markers, GFAP and GS. All cells in
the ONL explants were positive for recoverin, confirming the
presence of photoreceptors. No GFAP- or GS-positive cells were
detected. Some remnants of Mu ¨ller cell basal processes could be
observed (arrows), demonstrating the purity of the photoreceptor
sheets. Positive control for GFAP and GS staining consisting of full
retina sections were included (data not shown). Scale bar is 20 mm.
Found at: doi:10.1371/journal.pone.0003554.s005 (5.04 MB TIF)
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